Merck & Co., Inc. (MRK) is expected to report earnings on Thursday, October 29, 2026, after the close. Estimated release time 06:44 ET. Consensus EPS estimate is $2.22.
| Report date | Quarter | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|---|
| 2026-08-04 | FY2026 Q2 | $-0.27 | $-0.13 | +51.9% | $16.61B |
| 2026-05-04 | FY2026 Q1 | $-1.47 | $-1.28 | +12.9% | $16.29B |
| 2026-02-24 | FY2025 Q4 | $2.01 | $2.04 | +1.5% | $16.40B |
| 2025-11-05 | FY2025 Q3 | $2.36 | $2.58 | +9.3% | $17.18B |
| 2025-08-05 | FY2025 Q2 | $2.03 | $2.13 | +4.9% | $15.80B |
| 2025-05-02 | FY2025 Q1 | $2.13 | $2.22 | +4.2% | $15.62B |
| 2025-02-25 | FY2024 Q4 | $1.85 | $1.72 | -7.0% | $15.62B |
| 2024-11-06 | FY2024 Q3 | $1.50 | $1.57 | +4.7% | $16.66B |
MRK has beaten consensus EPS in 7 of its last 8 reported quarters.
See MRK on the live calendar →